Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

CD26 (Dipeptidyl peptidase 4) (DPP4) inhibitors + Thiazolidinediones & Type 2 Diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

No fixed-dose combination products of CD26 (Dipeptidyl peptidase 4) (DPP4) inhibitors + Thiazolidinediones are FDA or EMA approved for Type 2 Diabetes (T2D). Both agencies approve concomitant use (separate tablets)
Saini et al. 2023 Front Mol Biosci 10: 1130625

DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature
Saini et al. 2023 Front Mol Biosci 10: 1130625
Review

7/1/2026